Non-invasive Advantage Opportunity to target healthcare providers and payers with a non-invasive neuromodulation solution for overactive bladder, positioning Vivally as a safer, patient-friendly alternative to surgery or drugs.

Digital Health Synergy Leverage the Vivally System’s wearable and mobile app to offer value-based care integrations, remote monitoring, and data-driven outcomes to urology clinics, rehab centers, and digital health platforms.

Expansion Readiness Recent C-suite changes and Series D funding indicate strategic growth; target partnerships for distribution, clinical adoption, and potential co-development with regional and global medical device distributors.

Market Access Focus Increase engagement with health plans and payer organizations through Michael Hoffman’s market access expertise to secure favorable reimbursement pathways and faster patient access.

Clinical Leadership Capitalize on leadership appointments and product marketing ramp; pursue partnerships for clinical education, key opinion leader programs, and adoption milestones in urology and neuromodulation niches.